Born from frozen camel blood, Ablynx is $4.8 billion prize

It began almost three decades ago with a container of frozen camel blood in Belgium, took a detour through Morocco and progressed to a stock listing in New York last year. The latest chapter in Ablynx's story: a takeover worth about $4.8 billion.

The biotech company -- which Monday agreed to a bid from France's Sanofi, snubbing a lower offer from Danish…